数字农科院2.0

Evaluation of residual virulence and protective efficacy for Brucella melitensis vaccine strain M5-90 in mice and guinea pigs

文献类型： 外文期刊

作者： Chenchen Lu;Chenglan Zhang;Yanan Li;Zujian Qiao;Xijun Wang;Weiye Chen;Xiaoyi Chen;Qian Jiang;Da Xu;Zhigao Bu;Sen Hu

作者机构：

关键词： Brucella;M5-90;Mice and guinea pigs;Protective Efficacy;Safety;Vaccine Strain

期刊名称： Veterinary Microbiology

ISSN： 0378-1135

年卷期： 2026 年 313 卷

页码：

收录情况： SCIE（2025版）

摘要： Brucellosis, a globally significant zoonosis caused by Brucella species, leads to severe reproductive complications including abortion and infertility in animals and humans. Vaccination remains a cornerstone strategy for the control of brucellosis transmission. The Brucella melitensis vaccine strain M5‑90 was developed in China during the 1970s–1980s by attenuation from virulent M28 strain. This study systematically evaluated the safety and protective efficacy of M5‑90 in mouse and guinea pigs models. Results indicated that M5‑90 was completely cleared from mice within 15 weeks after subcutaneous inoculation of 10⁸ CFU, exhibiting a 50 % recovery time (RT50) of 9.27 ± 1.26 weeks. Bacterial replication was not dose-dependent. The bacterial burden in M5‑90-infected mice reduced by 1–3 log10 compared with the virulent M28 group at a challenge dose of 10⁶ CFU (P ' 0.05). Immunization with 10⁵ CFU conferred significant protection against virulent B. melitensis M28 and B. abortus 544 challenges at 45 and 150 days post-vaccination, respectively (P ' 0.05 or P ' 0.01). In guinea pigs, the splenic bacterial load of M5‑90 was markedly lower than that in the M28 group (2440 ± 240 vs. 223,000 ± 3800 CFU/g; P ' 0.001). A dose of 3 × 10⁸ CFU of M5‑90 provided complete (100 %) and strong (90 %) protection against M28 and 544 challenges, respectively. In summary, Brucella melitensis vaccine strain M5‑90 demonstrates favorable safety and protective efficacy in mice and guinea pigs, supporting its potential as a promising vaccine for brucellosis control.

分类号：

  • 相关文献

[1]A safe and molecular-tagged Brucella canis ghosts confer protection against virulent challenge in mice. Qian, Jing,Bu, Zhaoyang,Lang, Xulong,Wang, Xinglong,Qian, Jing,Qian, Jing,Yan, Guangmou,Yang, Yanling,Wang, Xiuran.

[2]Protection Evaluation of a Five-Gene-Deleted African Swine Fever Virus Vaccine Candidate Against Homologous Challenge. Xie Z.,Liu Y.,Di D.,Liu J.,Gong L.,Chen Z.,Li Y.,Yu W.,Lv L.,Zhong Q.,Song Y.,Liao X.,Song Q.,Wang H.,Chen H.. 2022

[3]马耳它布氏杆菌bp26基因缺失株的构建及鉴定. 胡森,郑孝辉,王加兰,张倩,刘文兴,王喜军,乔祖建,刘林涛,高红霞,王君伟,步志高. 2009

[4]不同毒力马耳他种布鲁氏菌体内外诱导细胞凋亡的研究. 宗树成,许达,宋甲宝,姜丽英,刘文兴,李兆利,王金良,步志高,胡森. 2018

[5]Structural and biochemical insights into the V/I505T mutation found in the EIAV gp45 vaccine strain. Du, Jiansen,Ma, Jing,Wang, Jianxin,Liu, Fang,Qiao, Wentao,Liu, Xinqi,Wang, Xuefeng,Qin, Yuyin,Zhu, Chunhui,Zhou, Jianhua,Shao, Yiming,Shao, Yiming. 2014

[6]Cloning of the genome of a goose parvovirus vaccine strain SYG61v and rescue of infectious virions from recombinant plasmid in embryonated goose eggs. Wang, Jianye,Duan, Jinkun,Meng, Xia,Jiang, Zhiwei,Zhu, Guoqiang,Wang, Jianye,Duan, Jinkun,Meng, Xia,Jiang, Zhiwei,Zhu, Guoqiang,Gong, Jiansen. 2014

[7]Protective efficacy of pVAX-RON5p against acute and chronic infections of Toxoplasma gondii in BALB/c mice. Zhao, Yu,Li, Zhong-Yuan,Chen, Jia,Liu, Shan-Shan,Zhu, Xing-Quan,Zhou, Dong-Hui,Zhao, Yu,Sun, Xiao-Lin,Li, Zhong-Yuan,Liu, Shan-Shan,Zhu, Xing-Quan.

[8]Deletion of the BAC sequences from recombinant meq-null Marek's disease (MD) virus increases immunosuppression while maintaining protective efficacy against MD. Su, S.,Cui, N.,Sun, P.,Cui, Z.,Li, J.,Li, H.,Li, Y..

[9]Construction and immune effect of Haemophilus parasuis DNA vaccine encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in mice. Bei, Weicheng,Fu, Shulin,Ou, Jiwen,Tan, Chen,Chen, Huanchun,Bei, Weicheng,Zhang, Minmin,Liu, Jinlin. 2012

[10]Expression of truncated Babesia microti apical membrane protein 1 and rhoptry neck protein 2 and evaluation of their protective efficacy. Wang, Guanbo,Efstratiou, Artemis,Moumouni, Paul Franck Adjou,Liu, Mingming,Jirapattharasate, Charoonluk,Guo, Huanping,Gao, Yang,Suzuki, Hiroshi,Igarashi, Ikuo,Xuan, Xuenan,Cao, Shinuo,Zhou, Mo.

[11]Protective efficacy of a high-growth reassortant swine H3N2 inactivated vaccine constructed by reverse genetic manipulation. Wen, Feng,Ma, Ji-Hong,Yu, Hai,Yang, Fu-Ru,Huang, Meng,Zhou, Yan-Jun,Li, Ze-Jun,Tong, Guang-Zhi.

[12]Recombinant duck enteritis viruses expressing major structural proteins of the infectious bronchitis virus provide protection against infectious bronchitis in chickens. Li, Huixin,Wang, Yulong,Han, Zongxi,Wang, Yu,Liang, Shulin,Jiang, Lu,Kong, Xiangang,Liu, Shengwang,Wang, Yulong,Hu, Yonghao.

[13]Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens. Tian, Guobin,Chen, Hualan.

[14]Effects of different promoters on the protective efficacy of recombinant Marek's disease virus type 1 expressing the VP2 gene of infectious bursal disease virus. Li, Kai,Liu, Yongzhen,Liu, Changjun,Gao, Li,Zhang, Yanping,Gao, Yulong,Cui, Hongyu,Qi, Xiaole,Zhong, Li,Wang, Xiaomei.

[15]Evaluation of two strains of Mareles disease virus serotype 1 for the development of recombinant vaccines against very virulent infectious bursal disease virus. Li, Kai,Liu, Yongzhen,Liu, Changjun,Gao, Li,Gao, Yulong,Zhang, Yanping,Cui, Hongyu,Qi, Xiaole,Zhong, Li,Wang, Xiaomei.

[16]Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine. Zheng, Haixue,Lian, Kaiqi,Yang, Fan,Jin, Ye,Zhu, Zixiang,Guo, Jianhong,Cao, Weijun,Liu, Huanan,He, Jijun,Zhang, Keshan,Li, Dan,Liu, Xiangtao.

[17]Protective efficacy of a novel recombinant Marek's disease virus vector vaccine against infectious bursal disease in chickens with or without maternal antibodies. Li, Kai,Liu, Yongzhen,Zhang, Yanping,Gao, Li,Liu, Changjun,Cui, Hongyu,Qi, Xiaole,Gao, Yulong,Zhong, Li,Wang, Xiaomei.

[18]Protective Efficacy of the Inactivated H5N1 Influenza Vaccine Re-6 Against Different Clades of H5N1 Viruses Isolated in China and the Democratic People's Republic of Korea. Zeng, Xianying,Deng, Guohua,Liu, Liling,Li, Yanbing,Shi, Jianzhong,Chen, Pucheng,Feng, Huapeng,Tian, Guobin,Chen, Hualan,Zeng, Xianying,Deng, Guohua,Liu, Liling,Li, Yanbing,Shi, Jianzhong,Chen, Pucheng,Feng, Huapeng,Tian, Guobin,Chen, Hualan,Liu, Jingli,Guo, Xingfu,Mao, Shenggang,Yang, Fan,Chen, Zhiyu.

[19]Development of a new effective African swine fever virus vaccine candidate by deletion of the H240R and MGF505-7R genes results in protective immunity against the Eurasia strain. Li, Jiangnan,Song, Jie,Zhou, Shijun,Li, Shuai,Liu, Jia,Li, Tingting,Zhang, Zhaoxia,Zhang, Xianfeng,He, Xijun,Chen, Weiye,Zheng, Jun,Zhao, Dongming,Bu, Zhigao,Huang, Li,Weng, Changjiang. 2023

[20]Sequential Deletions of Interferon Inhibitors MGF110-9L and MGF505-7R Result in Sterile Immunity against the Eurasia Strain of Africa Swine Fever. Ding, Mingyang,Dang, Wen,Liu, Huanan,Zhang, Keshan,Xu, Fan,Tian, Hong,Huang, Huaguo,Shi, Zhengwang,Sunkang, Yongjie,Qin, Xiaodong,Zhang, Yong,Zheng, Haixue. 2022

作者其他论文 更多>>